Daniel Roberts

Daniel Roberts focuses his practice on intellectual property with an emphasis on life sciences patent litigation. He has argued before the U.S. Court of Appeals for the Federal Circuit and the U.S. District Court for the District of Delaware.

He was previously a research chemist in the pharmaceutical industry for nearly a decade, specializing in drug product design, high-throughput crystallization, small molecule and protein crystallography, and tech transfer. His research areas were virology, metabolic disorders, cardiovascular disorders and oncology, particularly PD1/PDL1. He is a named inventor on numerous patents and patent applications, including U.S. Patent No. 8,759,372 (Roberts et al.) directed to a crystal form of a CGRP antagonist. His writing has appeared in Reuters, JD Supra, NYIPLA: The Report, Law360 and Crystal Growth & Design.

Mr. Roberts maintains an active pro bono practice, working with veterans to secure government benefits in the Court of Appeals for Veterans’ Claims and the U.S. Court of Appeals for the Federal Circuit, as well as assisting victims of battery or extreme cruelty in obtaining lawful permanent residence in the U.S.

Genzyme Corp. et al. v. Novartis Gene Therapies et al. USA Inc. et al. (D. Del.). Representing Sanofi and Genzyme in a patent infringement suit involving multiple patents relating to rAAV vectors.
Boston Scientific Corporation et al. v. Micro-Tech Endoscopy USA Inc. et al. (D. Del.). Represented Boston Scientific in a patent infringement suit involving multiple patents relating to endoscopic hemostasis clips. Matter settled favorably.
Vectura Ltd. v. GlaxoSmithKline LLC (D. Del.). Represented GlaxoSmithKline defending patent infringement action at trial.
In re Opana ER Antitrust Litigation (N.D. Ill.). Represented Endo Pharmaceuticals defending against antitrust claims. Jury found for Endo that settlement at issue was not anti-competitive.
Par Pharmaceutical, Inc. et al. v. Cipla Ltd. et al. (D.N.J.). Representing Par Pharmaceutical, Inc. in Hatch-Waxman case filed against generic company involving Par's ready-to-use VASOSTRICT® product. Case is ongoing.
Agape Hospice Care v. Agape Care Group (N.D. Ga.). Representing Agape Care Group defending against Lanham Act claims. Successfully defended against issuance of preliminary injunction.
The Cousteau Society, Inc. v. Celine Cousteau et al. (D. Conn.; S.D.N.Y.). Represented The Cousteau Society in bringing trademark, unfair competition, and false association claims against competitor. Matter settled favorably.